Insulin resistance syndrome, body mass index and the risk of ischemic heart disease

CMAJ. Canadian Medical Association Journal

Volumn 172, Issue 10, 2005, Pages 1301-1305

  St Pierre, Annie C ^a,b   Cantin, Bernard ^c   Mauriège, Pascale ^d   Bergeron, Jean ^b   Dagenais, Gilles R ^c   Després, Jean Pierre ^c   Lamarche, Benoît ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c LAVAL UNIVERSITY   (Canada)

^d UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; HIGH RISK PATIENT; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; REGRESSION ANALYSIS; RISK FACTOR;

EID: 19744368235     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: 10.1503/cmaj.1040834     Document Type: Article

References (19)

1. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37: 1495-507.
2. Despres JP. Abdominal obesity as important component of insulin-resistance syndrome. Nutrition 1993;9(5):452-9.
3. Reaven GM. The insulin resistance syndrome. Curr Atheroscler Rep 2003;5(5): 364-71.
4. Despres JP. Inflammation and cardiovascular disease: Is abdominal obesity the missing link? Int J Obes Relat Metab Disord 2003;27(Suppl 3):S22-24.
5. Carey DG, Jenkins AB, Campbell LV, Freund J, Chisholm DJ. Abdominal fat and insulin resistance in normal and overweight women: Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 1996;45(5):633-8.
6. St-Pierre AC, Ruel IL, Cantin B, Dagenais GR, Després JP, Lamarche B. Comparison of various electrophoretic characteristics of LDL particles and their relationship to the risk of ischemic heart disease. Circulation 2001;104: 2295-9.
7. Lamarche B, Despres JP, Moorjani S, Cantin B, Dagenais GR, Lupien PJ. Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Quebec Cardiovascular Study). Am J Cardiol 1995;75(17): 1189-95.
8. Dagenais GR, Robitaille NM, Lupien PJ, Christen A, Gingras S, Moorjani S, et al. First coronary heart disease event rates in relation to major risk factors: Québec cardiovascular study. Can J Cardiol 1990;6:274-80.
9. Lamarche B, Tchernof A, Dagenais GR, Cantin B, Lupien PJ, Després JP. Small, dense LDL particles and the risk of ischemic heart disease. Prospective results from the Québec Cardiovascular Study. Circulation 1997;95(1):69-75.
10. Pirro M, Bergeron J, Dagenais GR, Bernard PM, Cantin B, Despres JP, et al. Age and duration of follow-up as modulators of the risk of ischemic heart disease associated with high plasma C-reactive protein levels in men. Arch Intern Med 2001;161:2474-80.
11. Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996;334(15):952-7.
12. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO III, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107(3):499-511.
13. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults - The Evidence Report. National Institutes of Health. Obes Res 1998;6(Suppl 2):51S-209S.
14. Lamon-Fava S, Wilson PW, Schaefer EJ. Impact of body mass index on coronary heart disease risk factors in men and women. The Framingham Offspring Study. Arterioscler Thromb Vasc Biol 1996;16(12):1509-15.
15. Schulte H, von Eckardstein A, Cullen P, Assmann G. [Obesity and cardiovascular risk]. Herz 2001;26(3):170-7.
16. Stevens J, Cai J, Pamuk ER, Williamson DF, Thun MJ, Wood JL. The effect of age on the association between body-mass index and mortality. N Engl J Med 1998;338(1):1-7.
17. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287(3):356-9.
18. Solymoss BC, Bourassa MG, Campeau L, Sniderman A, Marcil M, Lesperance J, et al. Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity. Am J Cardiol 2004;93(2):159-64.
19. Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr 2004;79(3):379-84.